The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled study.
about
Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System BlockadePresent and future in the treatment of diabetic kidney diseaseThe role of uric acid in kidney fibrosis: experimental evidences for the causal relationship.Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis.Targeting Uric Acid and the Inhibition of Progression to End-Stage Renal Disease--A Propensity Score Analysis.Serum Uric Acid and Progression of Kidney Disease: A Longitudinal Analysis and Mini-ReviewManagement of Chronic Kidney Disease: The Relationship Between Serum Uric Acid and Development of NephropathyAsymptomatic hyperuricemia is a strong risk factor for resistant hypertension in elderly subjects from general population.Therapeutic approaches to diabetic nephropathy--beyond the RAS.Urate-lowering therapy: current options and future prospects for elderly patients with gout.Febuxostat for the chronic management of hyperuricemia in patients with gout.Time to target uric acid to retard CKD progression.A perspective on chronic kidney disease progression.Asymptomatic hyperuricemia and chronic kidney disease: Narrative review of a treatment controversial.Effect of Febuxostat, a Xanthine Oxidase Inhibitor, on Cardiovascular Risk in Hyperuricemic Patients with Hypertension: A Prospective, Open-label, Pilot Study.Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial.Lesinurad: what the nephrologist should know.Podocyte Injury and Albuminuria in Experimental Hyperuricemic Model Rats.Effects of uric acid-lowering therapy in patients with chronic kidney disease: A meta-analysis.The role of urate-lowering treatment on cardiovascular and renal disease: evidence from CARES, FAST, ALL-HEART, and FEATHER studies.Suggested statistical reappraisal of data from comparative study of febuxostat and allopurinol in chronic kidney disease.
P2860
Q26799443-60C79BE1-E1DB-460D-B4B0-F679ACE2671BQ26864133-4E97EEC9-0371-4D20-8323-FF0654055827Q33634704-BEF7B292-3D34-4A6F-BE37-BF4442D28F23Q35605560-FCACA663-C1CD-4E0D-B51D-D338271F4761Q35877440-70A541D6-2EE4-4C28-8642-AC9F8615EC75Q36255567-A9E3C989-56CD-43A8-A463-B3E00E5B11F7Q36373688-F2880090-9798-40AC-A82C-30862E110883Q37674063-C59D7743-70E9-427D-AB2D-6FC1BEE326AAQ38209811-345CF9AD-C258-4746-AC1C-62350EA15984Q38254304-B4999919-034F-4386-91C7-DB68D2985534Q38760404-F8273185-B2BC-457B-B669-7E070E873718Q38848997-BCA5974B-79B9-413C-BD7B-D8EB0E8638DBQ39038570-C2C9FE85-3294-4E3C-9BD0-779EA940AF25Q41026359-0DBC6236-C174-46FE-8B80-F29717174EB7Q41202631-E30E24D7-56D4-40F3-8490-CB65241A9165Q41444409-933EB1E0-9CDE-4B62-BA06-517E8F2D20AAQ42091820-6ED7B585-5402-40D2-AD0F-82AB79F94AF1Q42316455-1549B726-F6FD-4940-B5A0-CD35E289ADE4Q47138528-303A5E32-C263-4187-A863-095299FE7EE4Q49793137-53105245-1CA3-430B-AE9A-10FC5FACA384Q51784169-0FBEE6EA-E1DC-4240-8D6A-82C95F7F9DD8
P2860
The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The effect of febuxostat to pr ...... r randomized controlled study.
@en
The effect of febuxostat to pr ...... r randomized controlled study.
@nl
type
label
The effect of febuxostat to pr ...... r randomized controlled study.
@en
The effect of febuxostat to pr ...... r randomized controlled study.
@nl
prefLabel
The effect of febuxostat to pr ...... r randomized controlled study.
@en
The effect of febuxostat to pr ...... r randomized controlled study.
@nl
P2093
P2860
P356
P1433
P1476
The effect of febuxostat to pr ...... er randomized controlled study
@en
P2093
Hirofumi Makino
Hiroshi Hayakawa
Kenjiro Kimura
Masaaki Inaba
Naohiko Imai
Sadayoshi Itoh
Satoshi Iimuro
Seiichi Matsuo
Shunya Uchida
P2860
P2888
P356
10.1186/1745-6215-15-26
P577
2014-01-16T00:00:00Z
P5875
P6179
1048959316